Kathleen “Katie” Page, MD, MS
TRAX Unit Co-Lead; Director of Translational Science Accelerator
SC CTSI Role
Dr. Page's primary role is to lead the TRAX Pilots program. The TRAX Pilots program continues to be a major catalyst for the development of new interdisciplinary research teams and projects across USC, CHLA, and with other CTSA hubs.
Contact Information
Katie.page@usc.edu
323-442-2806
Professional Background
Dr. Katie Page is a Professor of Medicine and Pediatrics, Co-Chief of the Division of Endocrinology and Diabetes, and Director of the Diabetes and Obesity Research Institute at the Keck School of Medicine of the University of Southern California. For nearly two decades, her continuously NIH-funded research has combined neuroimaging, endocrinology, and developmental biology to understand three connected questions: how the brain and hormones regulate appetite and eating behavior; how a mother's metabolic health during pregnancy shapes a child's risk for obesity and diabetes; and how early-life exposure to diabetes may affect brain development and learning.
Her work has been recognized with the American Diabetes Association Pathway to Stop Diabetes Accelerator Award, along with honors from the Endocrine Society, the American Heart Association, and the Western Association of Physicians and Western Society for Clinical Investigation. Her research has been funded by the National Institutes of Health, the American Diabetes Association, the American Heart Association, and the Doris Duke Charitable Foundation.
Dr. Page earned her Bachelor of Science in Exercise Science and her medical degree (M.D.) at the University of Southern California, and a Master of Science in physiology at the University of Oklahoma. She completed a residency in Internal Medicine/Primary Care and a fellowship in Endocrinology, Diabetes and Metabolism at Yale School of Medicine, followed by a postdoctoral fellowship in neuroimaging sciences at Yale. She joined the faculty at the Keck School of Medicine of USC in 2009.
Her long-term vision is to identify the mechanisms and markers of disease in people at high risk for obesity and diabetes, whether related to in utero exposure to maternal metabolic disorders or other postnatal and environmental influences, and to develop and test interventions that prevent obesity and its related complications, especially in the children and families at greatest risk.
Interests
Dr. Page enjoys running, being outdoors, spending time family and friends, and drinking a strong cup of coffee.